ArticleCancers2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma.
Michael Müller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ArticleCancers2021
Michael Müller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.